FGF2 and cancer: Cells were cultured in absence of exogenous growth factors, exposing them to either hypoxia and to neutralizing antibodies targeting growth factors that are frequently deregulated in human cancers, including EGF, FGF-2, IGF-I, PDGF-BB, and VEGF-A.